After most cancer cells are killed, chemotherapy or radiation therapy creates aseptic inflammation due to the products of tumor cell disintegration remaining in the blood, which stimulates the NF-κB pathway to help surviving cancer cells to endure the toxicity of chemoradiotherapy. Here, NFKB1 is linked to cancer.